Emerging studies aim to better understand therapeutic interventions that may mitigate increased CVD risk in patients with RA.
All articles by Jasenka Piljac, PhD
The realization that IL-6 is implicated in many pathologic features of RA has prompted the search for IL-6-blocking agents as therapeutic options for this condition.
Publish Date
-
Latest News Your top articles for Thursday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses